First Alzheimer’s pill for genetically at high risk shows promise in phase 3 trial

Phase 3 clinical trial results of an investigational drug has shown benefits in treating people with APOE4/4 with early Alzheimer's disease.
 
MEDICALNEWSTODAY | DAILY NEWS
 
 
 
 
First Alzheimer's pill for genetically at high risk shows promise in phase 3 trial
 
READ ON
→
Weight loss drugs improve heart health regardless of amount of weight lost: study
 
READ ON
→
Skincare benefits of alpha hydroxy acid (AHA), and how to use it
 
READ ON
→
 
 
 
 
 
How are the gut microbiome and eczema connected?
 
 
 
 
Artificial sweeteners and brain aging: What we know so far
 
LISTEN ON Spotify   Listen on Apple Podcasts  
 
 
 
 
 
 
 
 
 
 
 
 
MNT
 
fb   tw   insta
 
 

Comments

Popular posts from this blog

Srotoshini Lyrics (স্রোতস্বিনী) Encore Band

New ‘aging clock’ reveals which habits affect longevity most

Bisher Churi Lyrics (বিষের ছুরি) Jisan Khan Shuvo